Cited by 741Cannabis and Cannabinoid ResearchInflammatory mediators and NSAID effectsNatural Compounds in Disease Treatment

The DOI matches its Crossref record; 131 of the 131 references it cites were found in a registry or an index.

Cannabinoid-based drugs as anti-inflammatory therapeutics

Klein, Thomas W.·2005·Nature Reviews Immunology

DOI 10.1038/nri1602

Open this paper in CoChat — free account

Abstract

In the nineteenth century, marijuana was prescribed by physicians for maladies ranging from eating disorders to rabies. However, as newer, more effective drugs were discovered and as the potential for abuse of marijuana was recognized, its use as a therapeutic became restricted, and only recently has its therapeutic potential been re-evaluated. Recent studies in animal models and in humans have produced promising results for the treatment of various disorders - such as obesity, cancer, and spasticity and tremor due to neuropathology - with drugs based on marijuana-derived cannabinoids. Moreover, as I discuss here, a wealth of information also indicates that these drugs have immunosuppressive and anti-inflammatory properties; therefore, on the basis of this mode of action, the therapeutic usefulness of these drugs in chronic inflammatory diseases is now being reassessed.

Integrity signals

Registry

Crossref · 10.1038/nri1602

Cites

131 of 131 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Toll-like receptor signalling
Akira, S., & Takeda, K. (2004) · Nature reviews. Immunology · doi:10.1038/nri1391 · Cited by 8,312
International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels
Catterall, W. A., Chandy, K. G., Clapham, D. E., Gutman, G. A., Hofmann, F., Harmar, A. J., Abernethy, D. R., & Spedding, M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.5 · Cited by 7,126
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Molecular characterization of a peripheral receptor for cannabinoids
Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors
Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913
International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
Howlett, A. C., Barth, F., Bonner, T. I., Cabral, G., Casellas, P., Devane, W. A., Felder, C. C., Herkenham, M., Mackie, K., Martin, B. R., et al. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.161 · Cited by 2,819
Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish
Gaoni, Y., & Mechoulam, R. (1964) · Journal of the American Chemical Society · doi:10.1021/ja01062a046 · Cited by 2,389
Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide
Zygmunt, P. M., Petersson, J., Andersson, D. A., Chuang, H.-H., Sørgård, M., Di Marzo, V., Julius, D., & Högestätt, E. D. (1999) · Nature · doi:10.1038/22761 · Cited by 2,142
The molecular logic of endocannabinoid signalling
Piomelli, D. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1247 · Cited by 1,957

Flagged first, then by citations

Show all 128 references

Sorted by citations

Items 201–300 of 741

Lipids as targets for novel anti-inflammatory therapies
Huwiler, A., & Pfeilschifter, J. M. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.06.008 · Cited by 60
Cannabinoids prevent the opposite regulation of astroglial connexin43 hemichannels and gap junction channels induced by pro‐inflammatory treatments
Froger, N., Orellana, J. A., Cohen‐Salmon, M., Ezan, P., Amigou, E., Sáez, J. C., & Giaume, C. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06407.x · Cited by 57
Cannabis in Parkinson’s Disease: The Patients’ View
Yenilmez, F., Fründt, O., Hidding, U., & Buhmann, C. (2020) · Journal of Parkinson s Disease · doi:10.3233/jpd-202260 · Cited by 59
Antioxidant function of phytocannabinoids: Molecular basis of their stability and cytoprotective properties under UV-irradiation
Vacek, J., Vostálová, J., Papoušková, B., Škařupová, D., Kos, M., Kabeláč, M., & Storch, J. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.01.012 · Cited by 56
Short- and long-term plasticity of the endocannabinoid system in neuropsychiatric and neurological disorders
Bisogno, T., & Marzo, V. D. (2007) · Pharmacological Research · doi:10.1016/j.phrs.2007.09.002 · Cited by 59
R-(+)-[2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)-pyrrolo-[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphtalenylmethanone (WIN-2) ameliorates experimental autoimmune encephalomyelitis and induces encephalitogenic T cell apoptosis: Partial involvement of the CB2 receptor
Sánchez, A., González-Pérez, P., Galve‐Roperh, I., & García‐Merino, A. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.08.018 · Cited by 56
Δ9 T etrahydrocannabinol attenuates Staphylococcal enterotoxin B ‐induced inflammatory lung injury and prevents mortality in mice by modulation of mi R ‐17‐92 cluster and induction of T ‐regulatory cells
Rao, R., Nagarkatti, P. S., & Nagarkatti, M. (2014) · British Journal of Pharmacology · doi:10.1111/bph.13026 · Cited by 56
Natural prenylated resveratrol analogs arachidin-1 and -3 demonstrate improved glucuronidation profiles and have affinity for cannabinoid receptors
Brents, L. K., Medina-Bolívar, F., Seely, K. A., Nair, V., Bratton, S. M., Ñopo-Olazabal, L., Patel, R. Y., Liu, H., Doerksen, R. J., Prather, P. L., et al. (2011) · Xenobiotica · doi:10.3109/00498254.2011.609570 · Cited by 55
Endocannabinoids and Their Receptors as Targets for Obesity Therapy
de Kloet, A. D., & Woods, S. C. (2009) · Endocrinology · doi:10.1210/en.2009-0046 · Cited by 55
Inflammatory Biomarkers in Addictive Disorders
Morcuende, Á., Navarrete, F., Nieto, E. O., Manzanares, J., & Femenía, T. (2021) · Biomolecules · doi:10.3390/biom11121824 · Cited by 55
Cannabinoid agonist WIN-55,212-2 partially restores neurogenesis in the aged rat brain
Marchalant, Y., Brothers, H. M., & Wenk, G. L. (2009) · Molecular Psychiatry · doi:10.1038/mp.2009.62 · Cited by 54
Immunomodulatory Lipids in Plants: Plant Fatty Acid Amides and the Human Endocannabinoid System
Gertsch, J. (2008) · Planta Medica · doi:10.1055/s-2008-1034302 · Cited by 54
Medical Marijuana for Digestive Disorders: High Time to Prescribe?
Gerich, M. E., Isfort, R. W., Brimhall, B. B., & Siegel, C. A. (2014) · The American Journal of Gastroenterology · doi:10.1038/ajg.2014.245 · Cited by 52
The endocannabinoid pathway and the female reproductive organs
Blasio, A. M. D., Vignali, M., & Gentilini, D. (2012) · Journal of Molecular Endocrinology · doi:10.1530/jme-12-0182 · Cited by 51
The Endocannabinoid/Cannabinoid Receptor 2 System Protects Against Cisplatin-Induced Hearing Loss
Ghosh, S., Sheth, S., Sheehan, K. E., Mukherjea, D., Dhukhwa, A., Borse, V., Rybak, L. P., & Ramkumar, V. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00271 · Cited by 55
Analgesic efficacy of cannabinoids for acute pain management after surgery: a systematic review and meta-analysis
Abdallah, F. W., Hussain, N., Weaver, T. E., & Brull, R. (2020) · Regional Anesthesia & Pain Medicine · doi:10.1136/rapm-2020-101340 · Cited by 57
PET Radioligands for In Vivo Visualization of Neuroinflammation
Ory, D., Celen, S., Verbruggen, A., & Bormans, G. M. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666140613120212 · Cited by 53
Immunomodulatory Potential of Cannabidiol in Multiple Sclerosis: a Systematic Review
Furgiuele, A., Cosentino, M., Ferrari, M., & Marino, F. (2021) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-021-09982-7 · Cited by 59
Bilateral Changes of Cannabinoid Receptor Type 2 Protein and mRNA in the Dorsal Root Ganglia of a Rat Neuropathic Pain Model
Svíženská, I. H., Brázda, V., Klusáková, I., & Dubový, P. (2013) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155413491269 · Cited by 52
Cannabinoid type 2 receptor stimulation attenuates brain edema by reducing cerebral leukocyte infiltration following subarachnoid hemorrhage in rats
Fujii, M., Sherchan, P., Krafft, P. R., Rolland, W. B., Soejima, Y., & Zhang, J. H. (2014) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2014.04.034 · Cited by 49
Cannabis smoking and serum C-reactive protein: A quantile regressions approach based on NHANES 2005–2010
Alshaarawy, O., & Anthony, J. C. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.11.017 · Cited by 51
Analysis of Natural and Induced Variation in Tomato Glandular Trichome Flavonoids Identifies a Gene Not Present in the Reference Genome
Kim, J., Matsuba, Y., Ning, J., Schilmiller, A. L., Hammar, D., Jones, A. D., Pichersky, E., & Last, R. L. (2014) · The Plant Cell · doi:10.1105/tpc.114.129460 · Cited by 51
Targeting the Endocannabinoid System in Alzheimer's Disease
Koppel, J. L., & Davies, P. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-15315 · Cited by 51
Inhibition of fatty acid amide hydrolase by kaempferol and related naturally occurring flavonoids
Thors, L., Belghiti, M., & Fowler, C. J. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.237 · Cited by 51
Endocannabinoids and Liver Disease. III. Endocannabinoid effects on immune cells: implications for inflammatory liver diseases
Pacher, P., & Gao, B. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00523.2007 · Cited by 51
Concomitant consumption of marijuana, alcohol and tobacco in oral squamous cell carcinoma development and progression: Recent advances and challenges
Lopes, C. F. B., de Angelis, B. B., Prudente, H. M., de Souza, B. V. G., Cardoso, S. V., & Ribeiro, R. I. M. D. A. (2012) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2012.05.006 · Cited by 50
Cannabinoid 1 Receptors in Keratinocytes Modulate Proinflammatory Chemokine Secretion and Attenuate Contact Allergic Inflammation
Gaffal, E., Cron, M., Glodde, N., Bald, T., Kuner, R., Zimmer, A., Lutz, B., & Tüting, T. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201777 · Cited by 50
Discovery and Optimization of a Novel Series ofN-Arylamide Oxadiazoles as Potent, Highly Selective and Orally Bioavailable Cannabinoid Receptor 2 (CB2) Agonists
Cheng, Y., Albrecht, B. K., Brown, J., Buchanan, J. L., Buckner, W. H., DiMauro, E. F., Emkey, R., Fremeau, R. T., Harmange, J.-C., Hoffman, B. J., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800463f · Cited by 49
Endocannabinoid System and the Kidneys: From Renal Physiology to Injury and Disease
Chua, J. T., Argueta, D. A., DiPatrizio, N. V., Kovesdy, C. P., Vaziri, N. D., Kalantar‐Zadeh, K., & Moradi, H. (2019) · Cannabis and Cannabinoid Research · doi:10.1089/can.2018.0060 · Cited by 51
Therapeutic Potential of Cannabinoid-Based Drugs
Klein, T., & Newton, C. A. (2007) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-72005-0_43 · Cited by 49
Self-citation
Antimicrobial potential of endocannabinoid and endocannabinoid-like compounds against methicillin-resistant Staphylococcus aureus
Feldman, M., Smoum, R., Mechoulam, R., & Steinberg, D. (2018) · Scientific Reports · doi:10.1038/s41598-018-35793-7 · Cited by 48
Epigenetics and the endocannabinoid system signaling: An intricate interplay modulating neurodevelopment
Gomes, T. M., da Silva, D. D., Carmo, H., Carvalho, F. D., & Silva, J. P. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105237 · Cited by 49
Differential Expression of Intracellular and Extracellular CB2 Cannabinoid Receptor Protein by Human Peripheral Blood Leukocytes
Castaneda, J. T., Harui, A., Kiertscher, S. M., Roth, J. D., & Roth, M. D. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-012-9430-8 · Cited by 47
Cannabis and the skin
Shao, K., Stewart, C. L., & Grant-Kels, J. M. (2021) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2021.05.006 · Cited by 46
A Review of the Therapeutic Antitumor Potential of Cannabinoids
Bogdanović, V., Mrdjanović, J., & Borišev, I. Đ. (2017) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2017.0016 · Cited by 47
Cannabinoids: Potential Role in Inflammatory and Neoplastic Skin Diseases
Milando, R., & Friedman, A. (2018) · American Journal of Clinical Dermatology · doi:10.1007/s40257-018-0410-5 · Cited by 50
Expression of the endocannabinoid system in fibroblasts and myofascial tissues
McPartland, J. M. (2008) · Journal of Bodywork and Movement Therapies · doi:10.1016/j.jbmt.2008.01.004 · Cited by 46
Endocannabinoid content in fetal bovine sera — Unexpected effects on mononuclear cells and osteoclastogenesis
Marazzi, J., Kleyer, J., Paredes, J. M. V., & Gertsch, J. (2011) · Journal of Immunological Methods · doi:10.1016/j.jim.2011.08.021 · Cited by 45
Emerging Therapeutic Targets of Sepsis-Associated Acute Kidney Injury
Swaminathan, S., Rosner, M. H., & Okusa, M. D. (2015) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2015.01.005 · Cited by 45
Cannabinoid receptor ligands as potential anticancer agents – high hopes for new therapies?
Oesch, S., & Gertsch, J. (2009) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.61.07.0002 · Cited by 45
Asthma associated with the use of cocaine, heroin, and marijuana: A review of the evidence
Self, T. H., Shah, S. P., March, K. L., & Sands, C. W. (2016) · Journal of Asthma · doi:10.1080/02770903.2016.1259420 · Cited by 45
Cannabinoid Actions on Neural Stem Cells: Implications for Pathophysiology
Rodrigues, R. S., Lourenço, D. M., Paulo, S. L., Mateus, J. M., Ferreira, M. F., Mouro, F. M., Moreira, J. B., Ribeiro, F. F., Sebastião, A. M., & Xapelli, S. (2019) · Molecules · doi:10.3390/molecules24071350 · Cited by 47
Polypharmacological Approaches for CNS Diseases: Focus on Endocannabinoid Degradation Inhibition
Papa, A., Pasquini, S., Contri, C., Gemma, S., Campiani, G., Butini, S., Varani, K., & Vincenzi, F. (2022) · Cells · doi:10.3390/cells11030471 · Cited by 49
Potential Therapeutical Contributions of the Endocannabinoid System towards Aging and Alzheimer’s Disease
Amandine, E. B., & Marchalant, Y. (2015) · Aging and Disease · doi:10.14336/ad.2015.0617 · Cited by 43
Activation of type 2 cannabinoid receptors (CB2R) promotes fatty acid oxidation through the SIRT1/PGC-1α pathway
Zheng, X., Sun, T., & Wang, X. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.05.108 · Cited by 43
Cannabinoid Receptors and Their Relationship With Chronic Pain: A Narrative Review
Anthony, A. T., Rahmat, S., Sangle, P., Sandhu, O., & Khan, S. (2020) · Cureus · doi:10.7759/cureus.10436 · Cited by 45
Scientific Validation of Cannabidiol for Management of Dog and Cat Diseases
Alvarenga, I. C., Panickar, K. S., Hess, H., & McGrath, S. (2023) · Annual Review of Animal Biosciences · doi:10.1146/annurev-animal-081122-070236 · Cited by 47
Mass spectrometry for the evaluation of cardiovascular diseases based on proteomics and lipidomics
Thomas, A., Lenglet, S., Chaurand, P., Déglon, J., Mangin, P. J., Mach, F., Steffens, S., Wolfender, J., & Staub, C. (2011) · Thrombosis and Haemostasis · doi:10.1160/th10-12-0812 · Cited by 41
Anti-inflammatory activity of cannabinoid receptor 2 ligands in primary hPDL fibroblasts
Abidi, A. H., Presley, C. S., Dabbous, M. K., Tipton, D. A., Mustafa, S. M., & Moore, B. M., II (2017) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2017.12.005 · Cited by 42
Cannabinoids Reduce Inflammation but Inhibit Lymphocyte Recovery in Murine Models of Bone Marrow Transplantation
Khuja, I., Yekhtin, Z., Or, R., & Almogi‐Hazan, O. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030668 · Cited by 47
Evidence for the use of cannabinoids in Parkinson’s disease
Buhmann, C., Mainka, T., Ebersbach, G., & Gandor, F. (2019) · Journal of Neural Transmission · doi:10.1007/s00702-019-02018-8 · Cited by 42
New Natural Noncannabinoid Ligands for Cannabinoid Type-2 (CB2) Receptors
Gertsch, J., Raduner, S., & Altmann, K. (2006) · Journal of Receptors and Signal Transduction · doi:10.1080/10799890600942674 · Cited by 42
Drug-Induced Hypothermia in Stroke Models: Does it Always Protect?
Zhang, M., Wang, H., Zhao, J., Chen, C., Leak, R. K., Xu, Y., Vosler, P. S., Chen, J., Gao, Y., & Zhang, F. (2013) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527311312030010 · Cited by 41
GPR55 and its Interaction with Membrane Lipids: Comparison with Other Endocannabinoid-Binding Receptors
Gasperi, V., Dainese, E., Oddi, S., Sabatucci, A., & Maccarrone, M. (2012) · Current Medicinal Chemistry · doi:10.2174/09298673130108 · Cited by 41
Therapeutic Prospects of Cannabinoids in the Immunomodulation of Prevalent Autoimmune Diseases
Mesa, X. M. R., Vergara, A. F. M., Bolaños, L. A. C., Guevara-Moriones, N., Piñeros, A. L. M., & González, S. P. S. (2021) · Cannabis and Cannabinoid Research · doi:10.1089/can.2020.0183 · Cited by 43
Activation of cannabinoid receptor 2 alleviates glucocorticoid-induced osteonecrosis of femoral head with osteogenesis and maintenance of blood supply
Sun, H., Zhang, W., Yang, N., Xue, Y., Wang, T., Wang, H., Zheng, K., Wang, Y., Zhu, F., Yang, H., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04313-3 · Cited by 41
Endocannabinoid Modulation in Neurodegenerative Diseases: In Pursuit of Certainty
Vasincu, A., Rusu, R.-N., Ababei, D. C., Larion, M., Bild, W., Stanciu, G. D., Solcan, C., & Bild, V. (2022) · Biology · doi:10.3390/biology11030440 · Cited by 44
Beneficial effects of cannabinoids (CB) in a murine model of allergen-induced airway inflammation: Role of CB1/CB2 receptors
Braun, A., Engel, T., Aguilar‐Pimentel, J. A., Zimmer, A., Jakob, T., Behrendt, H., & Mempel, M. (2010) · Immunobiology · doi:10.1016/j.imbio.2010.09.004 · Cited by 41
Anandamide inhibits IL-12p40 production by acting on the promoter repressor element GA-12: possible involvement of the COX-2 metabolite prostamide E2
Correa, F., Docagne, F., Clemente, D., Mestre, L., Becker, C., & Guaza, C. (2008) · Biochemical Journal · doi:10.1042/bj20071329 · Cited by 41
The Role of Cannabinoids in Inflammatory Modulation of Allergic Respiratory Disorders, Inflammatory Pain and Ischemic Stroke
Pini, A., Mannaioni, G., Pellegrini-Giampietro, D. E., Passani, M. B., Mastroianni, R., Bani, D., & Masini, E. (2012) · Current Drug Targets · doi:10.2174/138945012800675786 · Cited by 41
The cannabinoid 2 receptor agonist β-caryophyllene modulates the inflammatory reaction induced by Mycobacterium bovis BCG by inhibiting neutrophil migration
Andrade-Silva, M., Corrêa, L. B., Candéa, A. L. P., Cavalher-Machado, S. C., Barbosa, H. S., Rosas, E. C., & Henriques, M. D. G. (2016) · Inflammation Research · doi:10.1007/s00011-016-0969-3 · Cited by 42
A Novel Observational Method for Assessing Acute Responses to Cannabis: Preliminary Validation Using Legal Market Strains
Bidwell, L. C., Mueller, R. L., YorkWilliams, S. L., Hagerty, S. L., Bryan, A. D., & Hutchison, K. E. (2018) · Cannabis and Cannabinoid Research · doi:10.1089/can.2017.0038 · Cited by 40
A new era of moisturizers
Chandan, N., Rajkumar, J. R., Shi, V. Y., & Lio, P. (2021) · Journal of Cosmetic Dermatology · doi:10.1111/jocd.14217 · Cited by 44
Pharmacological hypothermia: a potential for future stroke therapy?
Liu, K., Khan, H., Geng, X., Zhang, J., & Ding, Y. (2016) · Neurological Research · doi:10.1080/01616412.2016.1187826 · Cited by 39
Cannabis Sativa Smoke Inhalation Decreases Bone Filling Around Titanium Implants: A Histomorphometric Study in Rats
Filho, G. D. R. N., Cadide, T., Rosa, B. T., Neiva, T. G. G., Tunes, R. S., Peruzzo, D. C., Nociti, F. H., & Neto, J. B. C. (2008) · Implant Dentistry · doi:10.1097/id.0b013e31818c5a2a · Cited by 39
Potential Control of Multiple Sclerosis by Cannabis and the Endocannabinoid System
Pryce, G., & Baker, D. (2012) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152712801661310 · Cited by 39
Amidoalkylindoles as Potent and Selective Cannabinoid Type 2 Receptor Agonists with in Vivo Efficacy in a Mouse Model of Multiple Sclerosis
Shi, Y., Duan, Y., Ji, Y.-Y., Wang, Z., Wu, Y.-R., Gunosewoyo, H., Xie, X., Chen, J., Yang, F., Li, J., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00724 · Cited by 37
Mechanisms of action of cannabidiol in adoptively transferred experimental autoimmune encephalomyelitis
González‐García, C., Moreno‐Torres, I., García-Hernández, R., Campos-Ruíz, L., Rodríguez‐Esparragoza, L., Coronado, M. J., Grande, A. G., García‐Merino, A., & Sánchez, A. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2017.08.017 · Cited by 40
Anti-Inflammatory Activity of a CB2 Selective Cannabinoid Receptor Agonist: Signaling and Cytokines Release in Blood Mononuclear Cells
Capozzi, A., Caissutti, D., Mattei, V., Gado, F., Martellucci, S., Longo, A., Recalchi, S., Manganelli, V., Riitano, G., Garofalo, T., et al. (2021) · Molecules · doi:10.3390/molecules27010064 · Cited by 38
Cannabinoids and experimental models of multiple sclerosis
Kubajewska, I., & Constantinescu, C. S. (2009) · Immunobiology · doi:10.1016/j.imbio.2009.08.004 · Cited by 37
Cannabinoids in neuroinflammatory disorders: Focusing on multiple sclerosis, Parkinsons, and Alzheimers diseases
Abd‐Nikfarjam, B., Dolati‐Somarin, A., Rahimi, V. B., & Askari, V. R. (2023) · BioFactors · doi:10.1002/biof.1936 · Cited by 37
Cannabinoid-like anti-inflammatory compounds from flax fiber
Styrczewska, M., Kulma, A., Ratajczak‐Wielgomas, K., Amarowicz, R., & Szopa, J. (2012) · Cellular & Molecular Biology Letters · doi:10.2478/s11658-012-0023-6 · Cited by 37
The endocannabinoid system: A new entry in remote cell death mechanisms
Viscomi, M. T., Oddi, S., Latini, L., Bisicchia, E., Maccarrone, M., & Molinari, M. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.03.023 · Cited by 37
Targeting Cannabinoid Receptors as a Novel Approach in the Treatment of Graft-versus-Host Disease: Evidence from an Experimental Murine Model
Pandey, R., Hegde, V. L., Nagarkatti, M., & Nagarkatti, P. S. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.182717 · Cited by 37
Considerations for the Conduct of Clinical Trials with Antiinflammatory Agents in Cystic Fibrosis. A Cystic Fibrosis Foundation Workshop Report
Torphy, T. J., Allen, J. M., Cantin, A. M., Konstan, M. W., Accurso, F. J., Joseloff, E., Ratjen, F. A., & Chmiel, J. F. (2015) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201506-361ot · Cited by 36
WIN55,212-2 Inhibits Production of CX3CL1 by Human Astrocytes: Involvement of p38 MAP Kinase
Sheng, W. S., Hu, S., Ni, H. T., Rock, R. B., & Peterson, P. K. (2009) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-009-9147-5 · Cited by 36
Characterization of endocannabinoids and related acylethanolamides in the synovial fluid of dogs with osteoarthritis: a pilot study
Valastro, C., Campanile, D., Marinaro, M., Franchini, D., Piscitelli, F., Verde, R., Marzo, V. D., & Bello, A. D. (2017) · BMC Veterinary Research · doi:10.1186/s12917-017-1245-7 · Cited by 36
Cannabis and Exercise Science: A Commentary on Existing Studies and Suggestions for Future Directions
Gillman, A. S., Hutchison, K. E., & Bryan, A. D. (2015) · Sports Medicine · doi:10.1007/s40279-015-0362-3 · Cited by 36
A CB1/CB2 receptor agonist, WIN 55,212-2, exerts its therapeutic effect in a viral autoimmune model of multiple sclerosis by restoring self-tolerance to myelin
Arévalo‐Martín, Á., Molina‐Holgado, E., & Guaza, C. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.04.012 · Cited by 36
Novel pyrazole derivatives as neutral CB 1 antagonists with significant activity towards food intake
Manca, I., Mastinu, A., Olimpieri, F., Falzoi, M., Sani, M., Ruiu, S., Loriga, G., Volonterio, A., Tambaro, S., Bottazzi, M. E. H., et al. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.12.056 · Cited by 35
Endocannabinoid system in cardiovascular disorders - new pharmacotherapeutic opportunities
Reis, F., Cunha, P., Romão, A., Mascarenhas‐Melo, F., & Teixeira, H. M. (2011) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/0975-7406.84435 · Cited by 35
Therapeutical Potential of CB2 Receptors in Immune-Related Diseases
Leleu‐Chavain, N., Desreumaux, P., Chavatte, P., & Millet, R. (2014) · Current Molecular Pharmacology · doi:10.2174/1874467207666140219122337 · Cited by 37
Interactions between dietary oil treatments and genetic variants modulate fatty acid ethanolamides in plasma and body weight composition
Pu, S., Eck, P., Jenkins, D. J. A., Connelly, P. W., Lamarche, B., Kris‐Etherton, P. M., West, S. G., Liu, X., & Jones, P. J. H. (2016) · British Journal Of Nutrition · doi:10.1017/s0007114515005425 · Cited by 35
CB2 and GPR55 Receptors as Therapeutic Targets for Systemic Immune Dysregulation
Zhou, J., Burkovskiy, I., Yang, H.-W., Sardinha, J., & Lehmann, C. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00264 · Cited by 37
The role of 2-arachidonoylglycerol in the regulation of the tumor-immune microenvironment in murine models of pancreatic cancer
Qiu, C., Yang, L., Wang, B., Cui, L., Li, C., Zhuo, Y., Zhang, L., Zhang, S., Zhang, Q., & Wang, X. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108952 · Cited by 35
Pursuing paradoxical proconvulsant prophylaxis for epileptogenesis
Armstrong, C., Morgan, R. J., & Soltész, I. (2009) · Epilepsia · doi:10.1111/j.1528-1167.2009.02173.x · Cited by 35
A neurotransmitter system that regulates macrophage pro-inflammatory functions
Reyes-García, M. G., & García-Tamayo, F. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.06.024 · Cited by 33
A selective CB2 agonist protects against the inflammatory response and joint destruction in collagen-induced arthritis mice
Bai, J., Ge, G., Wang, Y., Zhang, W., Wang, Q., Wang, W., Guo, X., Yu, B., Xu, Y., Yang, H., et al. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109025 · Cited by 34
Modulation of cortisol levels, endocannabinoid receptor 1A, proopiomelanocortin and thyroid hormone receptor alpha mRNA expressions by probiotics during sole (Solea solea) larval development
Palermo, F. A., Mosconi, G., Avella, M., Carnevali, O., Verdenelli, M. C., Cecchini, C., & Polzonetti-Magni, A. M. (2011) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2011.02.009 · Cited by 34
Exposure of Adolescent Mice to Delta-9-Tetrahydrocannabinol Induces Long-Lasting Modulation of Pro- and Anti-Inflammatory Cytokines in Hypothalamus and Hippocampus Similar to that Observed for Peripheral Macrophages
Moretti, S., Franchi, S., Castelli, M., Amodeo, G., Somaini, L., Panerai, A. E., & Sacerdote, P. (2015) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-015-9592-2 · Cited by 32
Experimental Cannabinoid 2 Receptor Activation by Phyto-Derived and Synthetic Cannabinoid Ligands in LPS-Induced Interstitial Cystitis in Mice
Berger, G., Arora, N., Burkovskiy, I., Xia, Y., Chinnadurai, A., Westhofen, R., Hagn, G., Cox, A. R., Kelly, M., Zhou, J., et al. (2019) · Molecules · doi:10.3390/molecules24234239 · Cited by 33
Cannabinoid 1 receptors in keratinocytes attenuate fluorescein isothiocyanate‐induced mouse atopic‐like dermatitis
Gaffal, E., Glodde, N., Jakobs, M., Bald, T., & Tüting, T. (2014) · Experimental Dermatology · doi:10.1111/exd.12414 · Cited by 33
Local administration of WIN 55,212-2 reduces chronic granuloma-associated angiogenesis in rat by inhibiting NF-κB activation
Filippis, D. D., Russo, A., Stefano, D. D., Maiuri, M. C., Esposito, G., Cinelli, M. P., Pietropaolo, C., Carnuccio, R., Russo, G., & Iuvone, T. (2007) · Journal of Molecular Medicine · doi:10.1007/s00109-007-0188-z · Cited by 33
Marine Cyanobacterial Fatty Acid Amides Acting on Cannabinoid Receptors
Montaser, R., Paul, V. J., & Luesch, H. (2012) · ChemBioChem · doi:10.1002/cbic.201200502 · Cited by 32
The endocannabinoid N-arachidonoyl dopamine (NADA) selectively induces oxidative stress-mediated cell death in hepatic stellate cells but not in hepatocytes
Wojtalla, A., Herweck, F., Granzow, M., Klein, S., Trebicka, J., Huss, S., Lerner, R., Lutz, B., Schildberg, F. A., Knolle, P. A., et al. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00241.2011 · Cited by 33
A new face of endocannabinoids in pharmacotherapy. Part I: protective role of endocannabinoids in hypertension and myocardial infarction.
Zubrzycki, M., Liebold, A., Janecka, A. E., & Zubrzycka, M. (2014) · PubMed · Cited by 31
µ‐opioid receptor, β‐endorphin, and cannabinoid receptor‐2 are increased in the colonic mucosa of irritable bowel syndrome patients
Dothel, G., Chang, L., Shih, W., Barbaro, M. R., Cremon, C., Stanghellini, V., Ponti, F. D., Mayer, E. A., Barbara, G., & Sternini, C. (2019) · Neurogastroenterology & Motility · doi:10.1111/nmo.13688 · Cited by 30
Pain response to cannabidiol in induced acute nociceptive pain, allodynia, and hyperalgesia by using a model mimicking acute pain in healthy adults in a randomized trial (CANAB I)
Schneider, T., Zurbriggen, L., Dieterle, M., Mauermann, E., Frei, P., Mercer‐Chalmers‐Bender, K., & Ruppen, W. (2021) · Pain · doi:10.1097/j.pain.0000000000002310 · Cited by 32
Endocannabinoid system and its modulation of brain, gut, joint and skin inflammation
Osafo, N., Yeboah, K. O., & Antwi, A. O. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06366-1 · Cited by 35
Hepatic expression of endocannabinoid receptors and their novel polymorphisms in primary biliary cirrhosis
Floreani, A., Lazzari, R., Macchi, V., Porzionato, A., Variola, A., Colavito, D., Leon, A., Guido, M., Baldo, V., De, R., et al. (2009) · Journal of Gastroenterology · doi:10.1007/s00535-009-0122-y · Cited by 31

Authors: Klein, T. W.
Affiliations: University of South Florida (US)
Corresponding author: Klein, Thomas W.
ORCID: Klein, Thomas W.
Venue: Nature Reviews Immunology
Publisher: Springer Science and Business Media LLC
Published: 2005-05
Volume: 5
Issue: 5
Pages: 400-411
ISSN: 1474-1733 (ISSN-L)
1474-1741
DOI: 10.1038/nri1602
OpenAlex: W2072422429
Cited by: 728
References: 128
Citations by year: 2026: 15 · 2025: 29 · 2024: 25 · 2023: 27 · 2022: 31 · 2021: 46 · 2020: 46 · 2019: 35 · 2018: 26 · 2017: 42 · 2016: 31 · 2015: 33 · 2014: 39 · 2013: 32 · 2012: 32
FWCI: 5.06
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature reviews. Immunology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
Health Sciences › Medicine › Complementary and alternative medicine › Natural Compounds in Disease Treatment
Keywords: anti-inflammatory therapy, chronic inflammatory diseases, immunosuppression, cannabis, obesity, cancer, spasticity, tremor, neuropathology
MeSH terms: Animals, Anti-Inflammatory Agents, Cannabinoids, Cell Movement, T-Lymphocytes, Helper-Inducer, Humans, Immunity, Innate, Inflammation, Cytokines, Receptors, Cannabinoid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cannabinoid-based drugs as anti-inflammatory therapeutics

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks